BEARD BROS PHARMS

New York Opens Application Window For Cannabis Licenses

In 2022, New York State passed a law legalizing the use of recreational marijuana for adults. However, the licensing process has been slow and plagued with lawsuits, causing delays in the rollout of licenses to businesses and individuals hoping to enter the market.

On October 4th, New York’s State Office of Cannabis Management (OCM) announced the opening of the new application window for cannabis licenses, which comes as a significant development for the state’s marijuana industry, especially considering the negative impact of previous delays on small businesses and individuals from marginalized communities.

Types of Licenses Available

The OCM has announced several types of licenses available for those interested in entering the adult-use marijuana market in New York. These include cultivation, processing, distributor, retail, and microbusiness licenses. However, the majority of the available licenses – between 500 and 1,000 – are designated specifically for retail dispensaries.

It is also important to note that currently operational adult-use cultivators and processors can also apply for full non-conditional licenses during this window. This provides an opportunity for those already in the industry to expand their operations and become licensed under the new regulations.

Eligibility

The OCM has made it a priority to ensure that the adult-use marijuana market in New York is fair and equitable for all individuals and businesses involved. As such, they have outlined specific eligibility criteria for applicants, with a strong emphasis on social and economic equity (SEE) applicants.

SEE applicants include individuals from communities disproportionately impacted by past prohibition, minority and women-owned businesses, distressed farmers, and service-disabled veterans. These individuals will receive priority in the licensing process to help level the playing field in an industry that larger corporations have historically dominated.

According to the OCM, SEE entrepreneurs will be eligible for the following benefits in order to promote access and business viability: 

  • SEE applicants will receive a 50% reduction on application fees and application assistance from the Office. 
  •  Eligible SEE licensees will receive a 50% reduction in licensing fees and direct support through the Cannabis Hub and Incubator Program (CHIP). 
  •  Eligible SEE applicants will receive license review priority for adult-use cannabis licenses. 

Application Process

The application window for cannabis licenses opened on October 4th and will be open for 60 days. Interested individuals and businesses can submit their applications to the OCM during this time. It is important to note that there may be future application periods, so those who cannot apply during this window should keep an eye out for any announcements.

The application fees for SEE and general applicants are relatively low, with a 50% reduction for SEE applicants. This is in line with the OCM’s commitment to promoting social and economic equity in the industry.

The OCM has also implemented a lottery-style, random order queuing process for issuing licenses. This means all qualified applicants will be equally likely to receive a license. However, SEE applicants will receive license review priority per the OCM, giving them a higher chance of being selected.

General licenses will be valid for two years, after which they will need to be renewed. Licensees must also meet specific standards of operation to maintain their license status.

As New York opens its application window for cannabis licenses, there is one major factor that has the potential to significantly impact the market – multistate operators (MSOs). These are companies that have operations in multiple states and often hold a large share of the market in those states.

Recently, MSOs filed a lawsuit against the state in an attempt to gain quick entry into the recreational marijuana market. They argue that their vertically integrated operations and existing medical cannabis licenses would allow them to start fast and help the slow rollout of adult-use cannabis in New York.

Regulators have not yet disclosed information on the application window for MSOs with New York medical cannabis licenses, but it is expected to occur soon. This was not originally anticipated and may result in a more competitive market, with MSOs having the upper hand regarding resources and experience.

This could potentially hinder smaller businesses and SEE applicants from being competitive in the market. With the seemingly unlimited budgets and manpower that MSOs have, it could be tough not to be drowned out in the upcoming market. It remains to be seen how this will play out, but it is something to keep an eye on as the adult-use cannabis industry in New York continues to develop.

Overall, opening the application window for cannabis licenses in New York has sparked both excitement and concern. While it is understandable that measures needed to be taken to help small farmers and businesses already in the adult use program move their products, there are also concerns about the potential impact of allowing up to 1,500 licenses and eventually letting large MSOs into the market. It is essential that regulators continue to prioritize social and economic equity in the industry, especially for SEE applicants.

As the market develops, monitoring and addressing any potential adverse effects on smaller businesses by larger corporations with unlimited resources will be crucial. The ultimate goal should be a fair and competitive market that benefits all participants and promotes diversity in the cannabis industry.

So, while it is necessary to make adjustments to the current system, it is important to carefully consider the potential consequences and take steps to ensure a level playing field for all applicants.


Keep updated on all the latest news and updates in the Cannabis industry here at Beard Bros Pharms by signing up for our Friday Sesh Newsletter here. Always Dank and Never Spam!

One Response

  1. I’ve been consulting a pulmonary doctor and had a bronchial scope with the results suspicious but not diagnostic for cancer though the nodules are growing. Dr. wants me to talk with a surgeon. I’ll have another CT scan in November. I have an herbalist here in West Virginia but still limited. Have read some articles about cannabis oil. Limited knowledge as I’m 69+ years old. I do have a medical Mary Jane card😜 can’t smoke and gummy’s aren’t available in West Virginia as of yet. Any suggestions? Getting desperate here.

Leave a Reply

Your email address will not be published. Required fields are marked *

READ MORE CANNABIS NEWS
Archives
Categories

NYCA I MO I MA I COMN I OHNJ I ALAK I AZ I AR I CT I DE I FL I GA I HI I ID I IL I IN I IA I KS I KY I LA I ME I MD I MI I MS I MT I NE I NV I NH I NC I ND I OK I OR I PA I RI I SC I SD I TN I TX I UT I VT I VA I WA I  WV I WI I WY I

FINANCEMEDICALNATIONAL I VETERANSPOLITICSPSYCHEDELICS I EDWIN RUBIS I RETAIL SPOTLIGHT I INDUSTRY I EDUCATION I BUSINESS I CULTURE I  RECREATION I MEDICAL I CULTIVATION I MANUFACTURING I TECHNOLOGY I RESEARCH I INSIGHTS I 

Cannabis Education

What is CBC?